Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Increased
Reduced
Net increased
Funds Holding
3,290
Funds Holding Change
-10
Funds Holding Growth
-0.3%
Value
$1.01T
Holding in Top 10
1,154
Top 10 Change
-61
Top 10 Growth
-5%
Value Growth
-3%
New
98
Increased
1,498
Reduced
1,526
Closed
64
Capital Inflow
$29.3B
Capital Outflow
$31.1B
Net Capital Flow
-$1.82B
Capital Flow Change
-$13.3B
Calls
$11.2B
Puts
$11.4B
Net Calls
-$272M
Put/Call Ratio
1.02